3-149167992-ATT-ATTTT

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2

The NM_032383.5(HPS3):​c.2887+18_2887+19dupTT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0069 ( 8 hom., cov: 0)
Exomes 𝑓: 0.010 ( 18 hom. )

Consequence

HPS3
NM_032383.5 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: -0.188

Publications

0 publications found
Variant links:
Genes affected
HPS3 (HGNC:15597): (HPS3 biogenesis of lysosomal organelles complex 2 subunit 1) This gene encodes a protein containing a potential clathrin-binding motif, consensus dileucine signals, and tyrosine-based sorting signals for targeting to vesicles of lysosomal lineage. The encoded protein may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 3. [provided by RefSeq, Apr 2015]
CP (HGNC:2295): (ceruloplasmin) The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]
CP Gene-Disease associations (from GenCC):
  • aceruloplasminemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • disorder of iron metabolism and transport
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 3-149167992-A-ATT is Benign according to our data. Variant chr3-149167992-A-ATT is described in ClinVar as Benign. ClinVar VariationId is 1169104.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00695 (1045/150398) while in subpopulation SAS AF = 0.0198 (95/4788). AF 95% confidence interval is 0.0166. There are 8 homozygotes in GnomAd4. There are 540 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPS3NM_032383.5 linkc.2887+18_2887+19dupTT intron_variant Intron 16 of 16 ENST00000296051.7 NP_115759.2 Q969F9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPS3ENST00000296051.7 linkc.2887+18_2887+19dupTT intron_variant Intron 16 of 16 1 NM_032383.5 ENSP00000296051.2 Q969F9-1

Frequencies

GnomAD3 genomes
AF:
0.00695
AC:
1045
AN:
150284
Hom.:
8
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00186
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00186
Gnomad ASJ
AF:
0.00378
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0200
Gnomad FIN
AF:
0.0168
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00966
Gnomad OTH
AF:
0.00388
GnomAD2 exomes
AF:
0.00988
AC:
2036
AN:
206140
AF XY:
0.0105
show subpopulations
Gnomad AFR exome
AF:
0.00192
Gnomad AMR exome
AF:
0.00197
Gnomad ASJ exome
AF:
0.00732
Gnomad EAS exome
AF:
0.000328
Gnomad FIN exome
AF:
0.0179
Gnomad NFE exome
AF:
0.0106
Gnomad OTH exome
AF:
0.0100
GnomAD4 exome
AF:
0.0101
AC:
11520
AN:
1137512
Hom.:
18
Cov.:
18
AF XY:
0.0105
AC XY:
6037
AN XY:
577410
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00763
AC:
178
AN:
23342
American (AMR)
AF:
0.00175
AC:
72
AN:
41120
Ashkenazi Jewish (ASJ)
AF:
0.00577
AC:
133
AN:
23048
East Asian (EAS)
AF:
0.000678
AC:
24
AN:
35396
South Asian (SAS)
AF:
0.0185
AC:
1405
AN:
75742
European-Finnish (FIN)
AF:
0.0164
AC:
824
AN:
50272
Middle Eastern (MID)
AF:
0.00668
AC:
33
AN:
4940
European-Non Finnish (NFE)
AF:
0.0101
AC:
8397
AN:
835042
Other (OTH)
AF:
0.00934
AC:
454
AN:
48610
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.398
Heterozygous variant carriers
0
397
794
1190
1587
1984
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00695
AC:
1045
AN:
150398
Hom.:
8
Cov.:
0
AF XY:
0.00736
AC XY:
540
AN XY:
73418
show subpopulations
African (AFR)
AF:
0.00185
AC:
76
AN:
41042
American (AMR)
AF:
0.00186
AC:
28
AN:
15084
Ashkenazi Jewish (ASJ)
AF:
0.00378
AC:
13
AN:
3436
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5126
South Asian (SAS)
AF:
0.0198
AC:
95
AN:
4788
European-Finnish (FIN)
AF:
0.0168
AC:
172
AN:
10238
Middle Eastern (MID)
AF:
0.00345
AC:
1
AN:
290
European-Non Finnish (NFE)
AF:
0.00966
AC:
651
AN:
67404
Other (OTH)
AF:
0.00384
AC:
8
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
51
102
154
205
256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00835
Hom.:
479

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome Benign:1
Sep 27, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397710976; hg19: chr3-148885779; API